Inflammatory markers in preeclamptic patients

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 9, 2011, Pages 1469-1472

  Can, Murat ^a   Sancar, Eray ^a   Harma, Muge ^a   Guven, Berrak ^a   Mungan, Gorkem ^a   Acikgoz, Serefden ^a  

^a Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

High sensitive C reactive protein (hsCRP); Preeclampsia; Procalcitonin; Serum amyloid A (SAA)

Indexed keywords

AMYLOID A PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED FLUORESCENT IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATION; MEAN ARTERIAL PRESSURE; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INFLAMMATION; PRE-ECLAMPSIA; PREGNANCY; PROTEIN PRECURSORS; ROC CURVE; SERUM AMYLOID A PROTEIN;

SIA;

EID: 80052851609     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.232     Document Type: Article

References (22)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130-7.
2. Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of preeclampsia in the community. BMJ 2005;330:576-80. (Pubitemid 40380353)
3. Lorquet S, Pequeux C, Munaut C, Foidart JM. Aetiology and physiopathology of preeclampsia and related forms. Acta Clin Belg 2010;65:237-41.
4. Johnson AM. Tietz textbook of clinical chemistry and molecular diagnostics, 4th ed. Burtis CA, Ashwood ER, Bruns DE, editors. Philadelphia: Saunders Company, 2006. 533 pp.
5. Furlaneto CJ, Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun 2000;268:405-8. (Pubitemid 30119635)
6. Hatanaka E, Pereira RF, Campa A. The acute phase protein serum amyloid A primes neutrophils. FEMS Immunol Med Microbiol 2003;38:81-4. (Pubitemid 37297447)
7. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49:57-61.
8. Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology 2007;39:383-90. (Pubitemid 47221465)
9. Cetinkaya M, Ozkan H, Köksal N, Celebi S, Hacimustafaoǧlu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and followup of neonatal sepsis in premature infants. J Perinatol 2009; 29:225-31.
10. Uys A, Rapoport BL, Fickl H, Meyer PW, Anderson R. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, 6, 8 and 10. Eur J Cancer Care 2007;16:475-83.
11. American College of Obstetricians and Gynecologists Committee on Obstetric Practice, Diagnosis and management of preeclampsia and eclampsia, Int J Gynecol Obstet 2002;77:67-75.
12. Hwang HS, Kwon JY, Kim MA, Park YW, Kim YH. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynecol Obstet 2007;98:105-9. (Pubitemid 47044931)
13. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006;11:309-16. (Pubitemid 44038703)
14. Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol 2004;190:1177-8. (Pubitemid 38692192)
15. Benedetto C, Marozio L, Tavella AM, Salton L, Grivon S, Di Giampaolo F, et al. Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann N Y Acad Sci 2010;1205:106-17.
16. Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira- Leite L, et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 2005;123:46-51. (Pubitemid 41563092)
17. Swellam M, Samy N, Wahab SA, Ibrahim MS. Emerging role of endothelial and inflammatory markers in preeclampsia. Dis Markers 2009;26:127-33.
18. Ouyang YQ, Li SJ, Zhang Q, Cai HB, Chen HP. Interactions between inflammatory and oxidative stress in preeclampsia. Hypertens Pregnancy 2009;28:56-62.
19. García RG, Celedón J, Sierra-Laguado J, Alarcón MA, Luengas C, Silva F, et al. Raised C-reactive protein and impaired flowmediated vasodilation precede the development of pre-eclampsia. Am J Hypertens 2007;20:98-103. (Pubitemid 46019850)
20. Engin-Ustün Y, Ustun Y, Karabulut AB, Ozkaplan E, Meydanl? MM, Kafkasl? A, et al. Serum amyloid A levels are increased in pre-eclampsia. Gynecol Obstet Invest 2007;64:117-20. (Pubitemid 47294471)
21. Kristensen K, Wide SD, Lindstrom V, Schmidt C, Grubb A, Strevens H, et al. Serum amyloid a protein and C-reactive protein in normal pregnancy and preeclampsia. Gynecol Obstet Invest 2009;67:275-80.
22. Montagnana M, Lippi G, Albierio A, Scevarolli S, Salvagno GL, Franchi M, et al. Procalcitonin values in preeclamptic women are related to severity of disease. Clin Chem Lab Med 2008;46:1050-1. (Pubitemid 352000503)